Medical student writes of his experiences in the Breast Cancer Clinic and says he learned more about life and the role of healthcare providers in caring for patients than he ever thought possible.
Editor’s note: ICE, or Initial Clinical Experience, is a program for new University of Michigan medical students. Instead of spending their first term only in lecture halls, they are assigned to shadow clinical faculty and other health professionals. This gives them early connections with patients and families and an understanding of the roles and responsibilities of all healthcare team members within the system.
Where is the line between disease and life drawn? This was a question I constantly thought about during my Initial Clinical Experience during my first term as a medical student. I remember the moment I found out I would be placed in the Breast Cancer Clinic and my feeling of dread. I was worried that so early in medical school I would come face-to-face with cancer, and through it, with death. Continue reading →
Blue light cystoscopy offers a significant advance in bladder tumor detection and, in Michigan, is only offered at the U-M Comprehensive Cancer Center. It uses a special dye, along with a blue light inside the patient to make cancer tumors more visible to surgeons. Left: tumors as seen with a traditional white light; right: the same tumors more visible with a dye and blue light.
mCancerPartner sat down recently with Cheryl Lee, M.D., a surgeon and professor of urology, to discuss blue light cystoscopy, a technology that significantly improves the detection of non-muscle invasive (early stage) cancer of the bladder during surgery. Dr. Lee’s research focuses on improving quality of life and surgical outcomes for bladder cancer patients. She is active with the Bladder Cancer Advocacy Network, where she has served as president of its Scientific Advisory Board and is currently a member of the Board of Directors. She is Past-Chairman of the Bladder Cancer Think Tank.
mCancerPartner: Can you talk about bladder cancer tumors and the challenges they present in regard to removing all the cancer. Continue reading →
It’s estimated that as many as 50%-75% of cancer deaths in the United States are caused by human behavior. If you think about that, it means our lifestyle choices can significantly impact a diagnosis of cancer. What can we do about cancer prevention?
Although not all cancers can be prevented, there are some measures we can take to greatly reduce our risk of getting a diagnosis of cancer.
Some patients with cancer experience a serious financial burden. A new study finds the burden is worse for patients without paid sick leave. In a survey of more than 1,300 patients with stage 3 colorectal cancer, researchers found that only 55% who were employed at the time of diagnosis retained their jobs after treatment. Patients who had paid sick leave were nearly twice as likely to retain their jobs as those without paid sick leave.
In the study, published in the Journal of the American Medical Association, the researchers found that patients without paid sick leave were more likely to report higher personal financial burden. This includes borrowing money, difficulties making credit card payments, reduced spending for food or clothing, or reduced recreational spending. Continue reading →
Is sugar our worst enemy? The simple answer is no. But the reason sugar can be bad for us is complex: Specifically, complex carbohydrates, or natural sugars in fruits and whole grains, are not the problem. These sugar-containing foods are actually treasure troves of anti-disease nutrients that should be included in a healthy diet.
What we need to limit is the added sugar in our diets, those sugars added in cooking and processing. And it’s not just in cakes, cookies and soft drinks. Added sugars are also found in tomato sauce, ketchup, salad dressings, cereals, crackers and breads. Continue reading →
While lung cancer is less common than cancers of the breast or prostate, it is responsible for nearly a third of all cancer deaths in the United States – 27% according to the American Cancer Society. The stigma of lung cancer being a “smoker’s disease” still persists despite the fact that 20% of deaths from lung cancer occur in those who never smoked. The last few years have been very exciting for lung cancer research. New immune and targeted therapies are available to treat this very deadly cancer.
Surprisingly, lung cancer is not one disease. It is classified into three types based upon the type and location of cell involved: small cell, non-small cell and lung carcinoid tumor. Continue reading →
NOTICE: Except where otherwise noted, all articles are published under a Creative Commons Attribution 3.0 license. You are free to copy, distribute, adapt, transmit, or make commercial use of this work as long as you attribute the University of Michigan Health System as the original creator and include a link to this article.